Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CXR Biosciences Resource Report Resource Website |
CXR Biosciences (RRID:SCR_003961) | commercial organization | Commercial organization that provides preclinical services and expertise, specializing in investigative toxicology, exploratory and discovery toxicology, metabolism and pharmacokinetics. CXR Biosciences is now Concept Life Sciences. | preclinical, toxicology, metabolism, pharmacokinetics, in vitro, in vivo, analytic, genomics, microarray, toxicogenomics, compound, drug | is related to: MIP-DILI | nlx_158363 | https://www.linkedin.com/company/cxr-biosciences-ltd | SCR_003961 | Concept Life Sciences, CXR Biosciences Ltd. | 2026-02-07 02:06:33 | 0 | ||||||||
|
GABO:mi Resource Report Resource Website |
GABO:mi (RRID:SCR_003956) | GABO:mi | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021. Small and medium-sized enterprise (SME) that is expert in management of research projects. Initially, they provide support with help and advice when applying for European research grants - free of charge. From project start, they take over contract negotiations, financial management, reporting to the EC, meeting organization, public relations and much more. ARTTIC Innovation GmbH took over GAVBO:mi. | project management |
is related to: OncoTrack is related to: European Lead Factory is related to: EU-AIMS is related to: NEWMEDS is related to: ARTTIC Innovation GmbH |
grid.10404.31, nlx_158356, ISNI: 0000 0004 0377 0748 | https://ror.org/00a99v816 | SCR_003956 | GABO:mi Gesellschaft f??r Ablauforganisation :milliarium mbH & Co. KG, GABO MI Society for workflow management, GABO:mi Gesellschaft fur Ablauforganisation:milliarium mbH & Co. KG, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co KG, GABO:mi Society for workflow management, GABO:mi Gesellschaft f??r Ablauforganisation:milliarium mbH & Co. KG, GABO:milliarium, GABO:mi Gesellschaft fur Ablauforganisation :milliarium mbH & Co. KG | 2026-02-07 02:06:13 | 0 | |||||||
|
Interface Europe Resource Report Resource Website |
Interface Europe (RRID:SCR_003955) | IE | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021.Commercial organization with expertise in European research and innovation that provide both science providers (researchers) and technology users (Industry including SMEs, public authorities, Universities, clusters, etc.) tailor-made services to give the highest possible European added value to their project. | European research and innovation |
is related to: MIP-DILI is parent organization of: MIP-DILI |
nlx_158364 | SCR_003955 | 2026-02-07 02:06:32 | 0 | |||||||||
|
Experimental Pharmacology and Oncology Berlin-Buch Resource Report Resource Website 1+ mentions |
Experimental Pharmacology and Oncology Berlin-Buch (RRID:SCR_003954) | EPO | commercial organization | A small and medium-sized enterprise (SME) that has expertise in preclinical pharmacology, pharmacokinetics, and toxicology for the characterization of novel anticancer therapeutics and predictive biomarkers like: cytostatics, biologicals (peptides, antibodies), (anti)-hormones, immunomodulators (cytokines), and gene therapeutics. EPO has modern laboratories licensed for animal experiments and gene technology (S2) and a broad panel of murine and human tumor models growing in immunocompetent (SPF-quality, syngeneic strains) or immunodeficient mice (nude, SCID, NOD/SCID). EPO has established imaging technologies to monitor in vivo tumor growth. | tumor model, pharmaceutical, oncology, in vitro, in vivo, antitumor, preclinical, pharmacology, pharmacokinetics, toxicology, anticancer, therapeutic, biomarker, imaging, testing, validation, target | is related to: OncoTrack | Tumor, Cancer | nlx_158355 | SCR_003954 | EPO - Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology Berlin-Buch, Experimental Pharmacology & Oncology Berlin-Buch GmbH, EPO Berlin-Buch GmbH, EPO-GmbH | 2026-02-07 02:06:11 | 2 | |||||||
|
Alacris Theranostics Resource Report Resource Website |
Alacris Theranostics (RRID:SCR_003953) | Alacris | commercial organization | Commercial organization that uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to identify individualized therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston. The company also is building up the first next generation sequencing center in Europe for clinical operations. | next generation sequencing, computational modeling, clinical trial, somatic tissue, genotyping, genomics, oncogenomics, diagnostics, therapy, disease model, drug, personalized medicine, biomarker, drug development, tumor model, analysis, oncology | is related to: OncoTrack | Tumor, Cancer | nlx_158354, grid.473915.d | https://ror.org/04a0gnr15 | SCR_003953 | Alacris Theranostics GmbH | 2026-02-07 02:06:13 | 0 | ||||||
|
Psynova Neurotech Resource Report Resource Website 1+ mentions |
Psynova Neurotech (RRID:SCR_003959) | Psynova | commercial organization | Commercial organization focused on the development and exploitation of novel biomarkers for psychiatric illnesses. They provide industrial and academic partners with comprehensive biomarker discovery services in commercial and collaborative projects. They operate in the field of psychiatric disorders and their products and services are designed to excel biomarker research. In 2010, Psynova Neurotech and its partner company Rules-Based-Medicine Inc (now MyriadRBM) conducted a beta launch of a blood test aiding in the diagnosis of schizophrenia (http://www.veripsych.com/). They are now refining the test and have shifted their focus to the development of new blood-based biomarker tests that aid in the diagnosis, prognosis and differential diagnosis of schizophrenia, bipolar disorder and major depression. They offer not only their pre-selceted Multiple Reaction Monitoring (MRM) and Multiplex Immunoassay products, but also custom build panels. If they are provided with a list of analyses to evaluate, they can produce an analytical panel according to individual needs utilizing either MRM or Multiplex Immunoassay technologies., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biomarker, neuropsychiatry, preclinical, model, diagnosis, blood, drug response, immunoassay, brain tissue, mass spectrometry, analysis |
is related to: University of Cambridge; Cambridge; United Kingdom is related to: NEWMEDS |
Schizophrenia, Psychiatric disorder, Bipolar Disorder, Major Depressive Disorder | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158360 | SCR_003959 | Psynova Neurotech Ltd | 2026-02-07 02:06:13 | 9 | ||||||
|
Coordinating center for infectious diseases Resource Report Resource Website |
Coordinating center for infectious diseases (RRID:SCR_003958) | CCID, CH | government granting agency | http://www.thecommunityguide.org/uses/funding.html | has parent organization: Centers for Disease Control and Prevention | nlx_inv_1005039 | SCR_003958 | 2026-02-07 02:06:33 | 0 | ||||||||||
|
Relypsa Resource Report Resource Website |
Relypsa (RRID:SCR_004047) | RLYP | commercial organization | Biopharmaceutical company focused on development and commercialization of non-absorbed polymeric drugs to treat disorders in areas of renal, cardiovascular and metabolic diseases.February 2021 - Relypsa changed its name to Vifor Pharma. Company is focused on development and commercialization of late stage medicines that will change treatment paradigms and improve patients lives. | biopharmaceutical, pharmaceutical, drug, late stage medicines, late stage medicines commercialization, late stage medicines development | is related to: Kidney Health Initiative | nlx_158475 | SCR_004047 | Relypsa Inc., Vifor Pharma | 2026-02-07 02:06:16 | 0 | ||||||||
|
Reata Pharmaceuticals Resource Report Resource Website 1+ mentions |
Reata Pharmaceuticals (RRID:SCR_004040) | Reata | commercial organization | Pharmaceutical company focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) and inhibit the pro-inflammatory transcription factor NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells). The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in their portfolio. | pharmaceutical, drug, immuno-oncology, ophthalmology, cardiovascular, autoimmune, respiratory, antioxidant inflammation modulator, oxidative stress, medicine, dermatology, skin, eye, clinical trial, nrf2, nf-b, bardoxolone methyl, rta 408, transcription, dna, transcription factor | is related to: Kidney Health Initiative | nlx_158468 | SCR_004040 | Reata Pharmaceuticals Inc. | 2026-02-07 02:06:16 | 2 | ||||||||
|
Otsuka America Pharmaceutical Inc. Resource Report Resource Website 1+ mentions |
Otsuka America Pharmaceutical Inc. (RRID:SCR_004036) | OAPI | commercial organization | Healthcare company that oversees all pharmaceutical and medical device commercial activities of Otsuka Group (Otsuka) in North America. Products with emphasis on neuroscience, oncology, cardio-renal, and medical device markets. | pharmaceutical, medical device, neuroscience, oncology, cardio-renal, commercial | is related to: Kidney Health Initiative | nlx_158462 | http://www.otsuka-us.com/Companies/OAPI/ | SCR_004036 | Otsuka America Pharmaceutical | 2026-02-07 02:06:35 | 1 | |||||||
|
Proteon Therapeutics Resource Report Resource Website 1+ mentions |
Proteon Therapeutics (RRID:SCR_004037) | Proteon | commercial organization | A biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases. Their ongoing Phase 3 clinical trial is evaluating whether a single treatment of PRT-201 can reduce vascular access failure, one of the most serious problems experienced by patients with chronic kidney disease (CKD) undergoing hemodialysis. PRT-201 is an investigational drug that may inhibit neointimal hyperplasia, the growth of tissue inside blood vessels that can result in vessel narrowing and reduced blood flow. PRT-201 has received fast track and orphan drug designations for hemodialysis vascular access indications.In September 2019, Proteon Therapeutics merged with ArTara Therapeutics. | biopharmaceutical, pharmaceutical, hemodialysis, prt-201, drug |
is related to: Kidney Health Initiative is related to: Protara Therapeutics |
Kidney disease, Vascular disease, Chronic kidney disease, Neointimal hyperplasia, Peripheral arterial disease | nlx_158465 | SCR_004037 | Proteon Therapeutics Inc. | 2026-02-07 02:06:16 | 1 | |||||||
|
Endocells Resource Report Resource Website 10+ mentions |
Endocells (RRID:SCR_004067) | Endocells | commercial organization | This resource no longer in service. Documented on August 12, 2021. French biotech company dedicated to human endocrine cell line production with a first focus on human pancreatic beta cell. Other cell types are being prepared like glucagon cells. The material will be powerful tools for drug discovery, toxicology and cell replacement therapy. Achievements to date * Generated tumoral and non-tumoral human beta cell lines which closely resemble human primary pancreatic beta cells (using technologies which have been first developed and validated using immortalized rat beta cell lines). World first. * Established a robust technology platform which will be used to develop other human endocrine cell lines. | pancreas, endocrine system, replacement cell therapy, glucagon, drug discovery, toxicology, pancreatic beta cell, cell line, human endocrine cell line, beta cell, glucagon cell, tumor |
is listed by: One Mind Biospecimen Bank Listing is related to: IMIDIA |
nlx_158504 | SCR_004067 | Endocells SARL, SARL Endocells | 2026-02-07 02:06:15 | 15 | ||||||||
|
Genomedics Resource Report Resource Website |
Genomedics (RRID:SCR_004103) | Genomedics | commercial organization | A commercial company specialized in the field of clinical governance, research and clinical-epidemiological analysis and development of services and software applications for healthcare. Products and Services * Analysis and development software solutions, web, e-learning * Design and Implementation APP for Smartphone and Tablet (iOS, Android, Windows Phone) * Clinical Intelligence & Clinical Decision Support Systems (CDSS) * Data center services and Application Server Provider * Epidemiology, Surveillance and Health Promotion - Development of studies and epidemiological research | healthcare, clinical, medicine, health, information service, analysis, software development, web portal, multimedia, e-learning, data center service, application server, business intelligence, epidemiology, surveillance, health promotion, population | is related to: EMIF | nlx_158578 | SCR_004103 | Genomedics health care consultants, Genomedics S.r.l. | 2026-02-07 02:06:18 | 0 | ||||||||
|
European ScreeningPort Resource Report Resource Website |
European ScreeningPort (RRID:SCR_004061) | ESP | commercial organization | Commercial organization that aims to bridge the gap between academia and the life-sciences industry with a wide ranging experience in pharmaceutical industry R&D covering multiple target classes and therapeutic areas. This deep scientific insight and established links with world class research institutions is applied across their business groups: * Drug Discovery * Biomarker and Translational Research * Enabling Technologies * R&D Information Technologies They measure their performance by successful outcomes for their collaborators, and recognize that an authentic partnership approach is essential in achieving the goal of converting outstanding science into high quality starting points for new medicines. | pharmaceutical |
is related to: Kinetics for Drug Discovery has parent organization: Mainz Institute of Molecular Biology Bioinformatics Core Facility |
German Federal Ministry of Education and Research ; Norgenta |
nlx_158497 | SCR_004061 | European Screening Port, European Screening Port GmbH, European ScreeningPort GmbH | 2026-02-07 02:06:14 | 0 | |||||||
|
W. L. Gore and Associates Resource Report Resource Website 1+ mentions |
W. L. Gore and Associates (RRID:SCR_004060) | Gore | commercial organization | An American manufacturing company specializing in products derived from fluoropolymers that focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. | medical device, implant, copper, optical, signal transmission, electronic, fabric, industrial product, medical product, contamination | is related to: Kidney Health Initiative | nlx_158494 | SCR_004060 | W. L. Gore & Associates Inc., W.L. Gore & Associates Inc., W.L. Gore and Associates, W. L. Gore & Associates, W.L. Gore & Associates | 2026-02-07 02:06:16 | 1 | ||||||||
|
Sierra Sensors Resource Report Resource Website 1+ mentions |
Sierra Sensors (RRID:SCR_004062) | commercial organization | In 2018 Bruker acquired Sierra Sensors GmbH, based in Hamburg, Germany. Sierra develops and manufactures innovative analytical biosensors based on Surface Plasmon Resonance (SPR) detection. Driven by patented technologies in the areas of SPR detection and microfluidic sample delivery, Sierra instruments are setting a new standard in high-throughput and high-performance label-free analysis. | biosensor, analytical tool, molecule, interaction, label-free analysis, analysis, assay, microfluidic, diagnostic | is related to: Kinetics for Drug Discovery | nlx_158499 | SCR_004062 | Sierra Sensors Biosensor Technologies, Sierra Sensors GmbH | 2026-02-07 02:06:37 | 1 | |||||||||
|
National Cancer Research Institute Resource Report Resource Website 1+ mentions |
National Cancer Research Institute (RRID:SCR_004057) | NCRI | institution | The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry which promotes co-operation in cancer research among the 22 member organizations for the benefit of patients, the public and the scientific community. Cancer affects everyone. One third of people in the UK get cancer at some time in their lives and a quarter of all people die from it. This means that even if we don''t have cancer ourselves, we know someone who does, or soon will. | is parent organization of: onCore UK | Crossref funder ID: 100008667, Wikidata: Q6971241, ISNI: 0000 0004 0578 6831, grid.451262.6, nlx_143544 | https://ror.org/02mp0vf47 | http://www.ncri.org.uk/default.asp | SCR_004057 | NCRI - National Cancer Research Institute | 2026-02-07 02:06:16 | 1 | |||||||
|
Vasculitis Foundation Resource Report Resource Website |
Vasculitis Foundation (RRID:SCR_004059) | VF | institution | An international organization for patients with vasculitis, their families, friends and the health care professionals who care for them, supporting and empowering them through education, awareness and research. The Foundation advocates for early diagnosis and leading edge treatment for all. The Foundation also partners with researchers around the world to determine the cause and discover the cure for vasculitis. | clinical, pediatric, child, funding resource | is related to: Kidney Health Initiative | Vasculitis | Crossref funder ID: 100007211, grid.453926.f, nlx_158493 | https://ror.org/03f9wqe45 | SCR_004059 | 2026-02-07 02:06:36 | 0 | |||||||
|
Boston University; Massachusetts; USA Resource Report Resource Website 1+ mentions |
Boston University; Massachusetts; USA (RRID:SCR_004054) | BU | university | Private research university in Boston, Massachusetts. The university is nonsectarian but maintains its historical affiliation with the United Methodist Church. It was founded in 1839 by Methodists with its original campus in Newbury, Vermont, before moving to Boston in 1867. |
uses: ResearchConnection is used by: ResearchConnection is related to: Alzheimers Disease Genetics Consortium is related to: International AMD Genetics Consortium is related to: Clinical and Translational Science Awards Consortium is related to: Piirus is parent organization of: EarLab is parent organization of: Evolutionary Lineage Inferred from Structural Analysis is parent organization of: Speech Language Disorders Database is parent organization of: Boston University Medical Campus; Massachusetts; USA is parent organization of: StellaBase: Nematostella vactensis genomics database is parent organization of: Tandem Repeats Database is parent organization of: Yeast Mitochondrial Protein Database is parent organization of: Boston University Department of Neuroscience is parent organization of: Many Microbe Microarrays Database is parent organization of: PRECISE is parent organization of: SIEGE- Smoking Induced Epithelial Gene Expression is parent organization of: Visionary: A Dictionary for the Study of Vision is parent organization of: Framingham Heart Study is parent organization of: Boston University School of Medicine; Massachusetts; USA is parent organization of: Boston University Labs and Facilities is parent organization of: Boston University Microarray Resource Core is parent organization of: CnidBase is parent organization of: OBART is parent organization of: Graph Theory GLM (GTG) MATLAB Toolbox is parent organization of: ClusPro is parent organization of: openEyeTrack project is parent organization of: Boston University Microarray and Sequencing Resource Core Facility is parent organization of: Teensy-Based Interface project |
Crossref funder ID:100007161, grid.189504.1, ISNI:0000 0004 1936 7558, nlx_75713, Wikidata:Q49110 | https://ror.org/05qwgg493 | SCR_004054 | Boston University | 2026-02-07 02:06:14 | 4 | ||||||||
|
University of Lodz; Lodz; Poland Resource Report Resource Website |
University of Lodz; Lodz; Poland (RRID:SCR_004053) | university | Public research university founded in 1945 in Łódź, Poland, as a continuation of educational institutions functioning in Łódź in the interwar period — the Teacher Training Institute, the Higher School of Social and Economic Sciences and a division of the Free Polish University. |
is related to: AddNeuroMed is related to: EARIP |
ISNI:0000 0000 9730 2769, grid.10789.37, nlx_158123, Crossref funder ID:501100005643, Wikidata:Q137503 | https://ror.org/05cq64r17 | SCR_004053 | Uniwersytet �dzki, University of �d, University of Lodz | 2026-02-07 02:06:16 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
